Progressive, Iovance Fall; Target, Take-Two Rise
Progressive, Iovance Fall; Target, Take-Two Rise
Target Corp., up $12.58 to $219.01.

NEW YORK: Target Corp., up $12.58 to $219.01.

The retailer blew away Wall Street’s first-quarter profit and revenue forecasts.

Take-Two Interactive Software Inc., up $11.66 to $179.35.

The publisher of Grand Theft Auto and other video games reported strong fiscal fourth-quarter financial results.

Tesla Inc., down $14.41 to $563.46.

The electric vehicle maker’s sales in China reportedly slumped in April.

Progressive Corp., down $4.98 to $101.

The insurance company’s first-quarter profit fell short of Wall Street forecasts.

Iovance Biotherapeutics Inc., down $10.64 to $16.33.

The biotechnology company expects to ask for regulatory approval of its lifileucel cancer therapy in the first half of 2022.

Myovant Sciences Ltd., down 77 cents to $21.83.

The FDA put a partial hold on a study for the biotechnology companys relugolix combination tablet as a contraceptive.

Reata Pharmaceuticals Inc., up $19.72 to $102.63.

The FDA wants to meet with the biotechnology company before it files for approval of a treatment for the rare genetic disease Friedreichs ataxia.

Eagle Materials Inc., down $8.32 to $139.25.

The construction and building materials company decided not to split into two separate companies.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.

What's your reaction?

Comments

https://rawisda.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!